August 11, 2021 – BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) announced that Christopher DelOrefice was named EVP and chief financial officer (CFO), effective September 6, 2021.
DelOrefice will join BD from Johnson & Johnson (J&J), where he is currently VP of Investor Relations. In nearly two decades at J&J, DelOrefice has also held a variety of senior finance leadership roles, including CFO of both the Consumer and Medical Devices segments for North America.
He also held finance leadership roles for J&J Supply Chain, Corporate Mergers and Acquisitions, Consumer Global R&D and the Pharmaceutical North America Business Development and Commercial Contracting Finance groups.
Prior to J&J, DelOrefice held leadership positions in cost accounting, global audit and financial reporting at Astra Zeneca Pharmaceuticals, AET Films, Inc. and Ametek, Inc.
At BD, DelOrefice succeeds Christopher Reidy, who announced his intent to retire from the company last week.
DelOrefice will gain immediate responsibility of the global finance organization when joining BD, and Reidy will transition the leadership of BD’s Technology & Global Services (TGS) organization to DelOrefice by the end of the calendar year.